Литература

1. Jackson G., Boon N., Eardley I., Kirby M., Dean J., Hackett G. et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int. J. Clin. Pract. 2010; 64: 848—57.

2. Montorsi P, Ravagnani PM., Galli S. et al. Association between erectile dysfunction and coro­nary artery disease: matching the right target with the right test in the right patient. Eur. Urol. 2006; 50: 721-31.

3. Montorsi F., Briganti A., Salonia A. et al. Erectile dysfunction prevalence, time of onset and associa­tion with risk factors in 300 consecutive patients with acute chest pain and angiographically docu­mented coronary artery disease. Eur. Urol. 2003; 44: 360-4.

4. Johannes C.B., Araujo A.B., Feldman H.A. et al. Incidence of erectile dysfunction in men 40 to 69 year old: longitudinal results from the Massachusetts male aging study. J. Urol. 2000; 163: 460-3.

5. NIH consensus development panel on impotence, NIH Consensus Conference. JAMA. 1993; 270 (1): 83-90.

6. Vlachopoulos C., Terentes-Printzios D., Ioakeimi- dis N. et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction. A sys­tematic review and meta-analysis of cohort studies. Circ. Cardiovasc. Qual. Outcomes. 2013; 6: 99-109.

7. Araujo A.B., Hall S.A., Ganz P., Chiu G.R., Rosen R.C., Kupelian V. et al. Does erectile dysfunc­tion contribute to cardiovascular disease risk predic­tion beyond the Framingham Risk Score? J. Am. Coll. Cardiol. 2010; 55: 350-6.

8. Bohm M., Baumhakel M., Teo K. et al. ONTAR- GET/TRANSCEND Erectile Dysfunction Sub­study Investigators. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTAR- GET/TRANSCEND). Trials. Circulation. 2010; 121: 1439-46.

9. Gazzaruso C., Solerte S.B., Pujia A. et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phos­phodiesterase inhibitors. J. Am. Coll. Cardiol. 2008; 51: 2040-4.

10. Chew K.K., Finn J., Stuckey B., Gibson N. Erectile dysfunction as a predictor for subsequent athero­sclerotic cardiovascular events: findings from a linked-data study. J. Sex. Med. 2010; 7 (1) (Pt. 1): 192-202.

11. Araujo A.B., Travison T.G., Ganz P. Erectile dys­function and mortality. J. Sex. Med. 2009; 6: 2445-54.

12. Brock G. Diagnosing erectile dysfunction could save your patient's life. Can. Urol. Assoc. J. 2014; 8 (7-8): S. 151-2.

13. Ewane K.A., Lin H.-Ch., Wang R. Should patients with erectile dysfunction be evaluated for cardiovas­cular disease? Asian. J. Androl. 2012; 14: 138-44.

14. Dong J.Y., Zhang Y.H., Qin L.Q. Erectile dysfunc­tion and risk of cardiovascular disease: meta-analy­sis of prospective cohort studies. J. Am. Coll. Cardiol. 2011; 58: 1378-85.

15. Gupta B.P., Clifton M.M., Prokop L. et al. The effect of lifestyle modification and cardiovascular risk fac­tor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch. Intern. Med. 2011; 171 (20): 1797-803.

16. Meller S.M., Stilp E, Walker Ch.N. et al. The link between vasculogenic erectile dysfunction, coro­nary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy. J. Inv Cardiol. 2013; 25 (6): 313-9.

17. Montorsi P, Montorsi F., Schulman C.C. Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder? Eur. Urol. 2003; 44: 352-4.

18. Cappelleri J.C., Rosen R.C. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J. Impot. Res. 2005; 17: 307-19.

19. Vlachopoulos C., Ioakeimidis N, Terentes-Printzi- os D., Stefanadis C. The triad erectile dysfunction- endothelial dysfunction-cardiovascular disease. Curr. Pharm. Des. 2008; 14: 3700-14.

20. Albersen M., Orabi H., Lue T.F. Evaluation and treatment of erectile dysfunction in the aging male: a mini-review. Gerontology. 2012; 58 (1): 3-14.

21. De Angelis L, Marfella M.A., Siniscalchi M. et al. Erectile and endothelial dysfunction in type II dia­betes: a possible link. Diabetologia. 2001; 44 (9): 1155-60.

22. Fournier G.R., Jr, Juenemann K.P., Lue T.F. et al. Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration. J. Urology. 1987; 137 (1): 163-7.

23. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010; 55: 1318-27.

24. Vlachopoulos C., Aznaouridis K., Ioakeimidis N. et al. Unfavorable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur. Heart J. 2006; 27: 2640-8.

25. Jackson G. Testosterone deficiency syndrome (TDS) and the heart. Eur. Heart J. 2010; 31: 1436-7.

26. Corona G., Rastrelli G., Monami M., Guay A., Buvat J., Sforza A. et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta­analytic study. Eur. J. Endocrinol. 2011; 165: 687-701.

27. Carson C.C., III, Rosano G. Exogenous testosterone, cardiovascular events, and cardiovascular risk fac­tors in elderly men: a review of trial data. J. Sex Med. 2012; 9: 54-67.

28. Haring R., Volzke H., Steveling A. et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur. Heart J. 2010; 31: 1494-501.

29. Ohlsson C., Barrett-Connor E., Bhasin S. et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J. Am. Coll. Cardiol. 2011; 58: 1674-81.

30. Montorsi P., Ravagnani P.M., Galli S. et al. Association between erectile dysfunction and coro­nary artery disease. Role of coronary clinical pre­sentation and extent of coronary vessels involve­ment: the COBRA trial. Eur. Heart J. 2006; 27: 2632-9.

31. Jackson G., Padley S. Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs. Int. J. Clin. Pract. 2008; 62: 973-6.

32. Vlachopoulos C., Rokkas K., Ioakeimidis N. et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur. Urol. 2005; 48: 996-1002.

33. Nehra A., Jackson G., Miner M. et al. The Prince­ton III Consensus recommendations for the man­agement of erectile dysfunction and cardiovascular disease. Mayo Clin. Proc. 2012; 87: 766-78.

34. Erne P., Schoenenberger A.W., Zuber M., Burck- hardt D., Kiowski W., Dubach P. et al. Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study. Eur. Heart J. 2007; 28: 2110-7.

35. Dahabreh I.J., Paulus J.K. Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis. JAMA. 2011; 305: 1225-33.

36. Levine G.N., Steinke E.E., Bakaeen F.G. et al. Sexual activity and cardiovascular disease: a scien­tific statement from the American Heart Associa­tion. Circulation. 2012; 125: 1058-72.

37. Miner M., Seftel A.D., Nehra A. et al. Prognostic utility of erectile dysfunction for cardiovascular dis­ease in younger men and those with diabetes. Am. Heart J. 2012; 164: 21-8.

38. Perk J., De Backer G., Gohlke H., Graham I., Rei­ner Z., Verschuren W.M. et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the european society of cardiology and other soci­eties on cardiovascular disease prevention in clinical practice (constituted by representatives of nine soci­eties and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 2012; 33: 1635-701.

39. Yeboah J., McClelland R.L., Polonsky T.S., Bur­ke G.L., Sibley C.T., O'Leary D. et al. Comparison of novel risk markers for improvement in cardiovas­cular risk assessment in intermediate-risk individu­als. JAMA. 2012; 308: 788-95.

40. Viigimaa M., Boutari C., Doumas M.Arterial hyper­tension and erectile dysfunction: an under-recog­nized duo. Cardiol. Pract. 2016; 14 (4). Available at: http://www.escardio.org/guidelines-&-education/ journals-and-publications/esc-journals-family/ e-journal-of-cardiology-practice/volume-14 (accessed 28 March 2016).

41. Vlachopoulos C., Ioakeimidis N., Rokkas K., Stefanadis C. Cardiovascular effects of phosphodi­esterase type 5 inhibitors. J. Sex. Med. 2009; 6: 658-74.

42. Frantzen J., Speel T.G., Kiemeney L.A., Meule- man E.J. Cardiovascular risk among men seeking help for erectile dysfunction. Ann. Epidemiol. 2006; 16: 85-90.

43. Baumhakel M., Schlimmer N, Kratz M. et al. Cardiovascular risk, drugs and erectile function — a systematic analysis. Int. J. Clin. Pract. 2011; 65: 289—98.

44. Silvestri A., Galetta P., Cerquetani E. et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur. Heart J. 2003; 24: 1928—32.

45. Manolis A., Doumas M.Antihypertensive treatment and sexual dysfunction. Curr. Hypertens. Rep. 2012; 14: 285—92.

46. Solomon H., Samarasinghe Y.P., Feher M.D. et al. Erectile dysfunction and statin treatment in high cardiovascular risk patients. Int. J. Clin. Pract. 2006; 60: 141—5.

47. Buvat J., Maggi M., Guay A., Torres L.O. Testo­sterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J. Sex. Med. 2013; 10: 245—84.

48. Basaria S., Coviello A.D., Travison T.G. et al. Adverse events associated with testosterone admin­istration. N. Engl. J. Med. 2010; 36: 109—22.

49. Kratz M.T., Schumacher H., Sliwa K. et al. Heart rate and blood pressure interactions in the develop­ment of erectile dysfunction in high-risk cardiovas­cular patients. Eur. J. Prevent. Cardiol. 2014; 21 (3): 272—80.

50. Grimm R.H., Grandits G.A., Prineas R.J. et al. Long­term effects on sexual function of five antihyperten­sive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997; 29: 8—14.

51. Apostolo A., Vignati C., Brusoni D., Cattadori G., Contini M., Veglia F. et al. Erectile dysfunction in heart failure: correlation with severity, exercise per­formance, comorbidities, and heart failure treat­ment. J. Sex. Med. 2009; 6: 2795—805.

52. Baraghoush A., Phan A., Willix R.D., Jr, Schwarz E.R. Erectile dysfunction as a complicationof heart fail­ure. Curr. Heart Fail. Rep. 2010; 7: 194—201.

Об авторах